Much research has focused on the basic cellular and molecular biological aspects of stem cells. Much of this research has been fueled by their potential for use in regenerative medicine applications, which has in turn spurred growing numbers of translational and clinical studies. However, more work is needed if the potential is to be realized for improvement of the lives and well-being of patients with numerous diseases and conditions.
This book series 'Cell Biology and Translational Medicine (CBTMED)' as part of Springer Nature's long-standing and very successful Advances in Experimental Medicine and Biology book series, has the goal to accelerate advances by timely information exchange. Emerging areas of regenerative medicine and translational aspects of stem cells are covered in each volume. Outstanding researchers are recruited to highlight developments and remaining challenges in both the basic research and clinical arenas. This current book is the twelfth volume of a continuing series.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Illustrationen
1
1 s/w Abbildung
VIII, 188 p. 1 illus.
Dateigröße
ISBN-13
978-3-030-71933-3 (9783030719333)
DOI
10.1007/978-3-030-71933-3
Schweitzer Klassifikation
Immune dysregulation and recurring mutations in myelodysplastic syndromes pathogenesis.- Stem Cell Aging and Regenerative Medicine.- Potential of Chimeric Antigen Receptor T-cells in cancer therapy.- Drug sensitivity and drug repurposing platform for cancer precision medicine.- Role and regulation of Lin28 in progenitor cells during central nervous system development.- Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspective.- Kaempferol induce cell death and sensitizes human head and neck squamous cell carcinoma cell lines to cisplatin.- A comprehensive approach to Urticaria: from clinical presentation to modern biological treatments through pathogenesis.- The potentials and pitfalls of using adult stem cells in cancer treatment.- The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.
